Plant Health Care plc Stock Börse Stuttgart

Equities

PC5

GB00B01JC540

Agricultural Chemicals

Delayed Börse Stuttgart 02:18:03 2024-05-29 EDT 5-day change 1st Jan Change
0.0655 EUR +3.15% Intraday chart for Plant Health Care plc -7.97% +73.97%

Financials

Sales 2023 * 11.2M 10.37M 15.36M Sales 2024 * 15.2M 14.07M 20.84M Capitalization 24.88M 23.03M 34.11M
Net income 2023 * -3M -2.78M -4.11M Net income 2024 * -1M -926K -1.37M EV / Sales 2023 * 2.06 x
Net cash position 2023 * 1.8M 1.67M 2.47M Net cash position 2024 * 1.5M 1.39M 2.06M EV / Sales 2024 * 1.54 x
P/E ratio 2023 *
-7.45 x
P/E ratio 2024 *
-16.5 x
Employees -
Yield 2023 *
-
Yield 2024 *
-
Free-Float 43.31%
More Fundamentals * Assessed data
Dynamic Chart
1 week-7.97%
Current month+58.75%
1 month+56.79%
3 months+58.75%
6 months+60.76%
Current year+73.97%
More quotes
1 week
0.06
Extreme 0.0635
0.07
1 month
0.04
Extreme 0.0385
0.07
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 15-05-05
Director of Finance/CFO 56 13-08-31
Chairman 70 12-07-31
Members of the board TitleAgeSince
Director/Board Member 69 19-10-31
Chairman 70 12-07-31
Director/Board Member 44 13-06-06
More insiders
Date Price Change
24-05-29 0.0655 +3.15%
24-05-28 0.0635 0.00%
24-05-27 0.0635 -6.62%
24-05-24 0.068 -2.86%
24-05-23 0.07 -4.76%

Delayed Quote Börse Stuttgart, May 29, 2024 at 02:18 am

More quotes
Plant Health Care plc provides peptides for plant protection for global agricultural markets. The Company offers products to improve the health, vigor and yield of various field crops, such as corn, soybeans, potatoes and rice, as well as specialty crops, such as fruits and vegetables. It operates globally through subsidiaries, distributors and supply agreements with various industry partners. Its biological products help growers to protect their crops from stress and diseases, and to produce fruit and vegetables. Its segments include Americas, Mexico and Rest of World. The Americas segment includes activities in both North and South America. The Mexico segment includes sales of Harpinab and third-party products. Harpinab is sold as H2Copla into sugar cane in Brazil, through Coplacana, which is a distributor of inputs for this crop. The Rest of World segment includes operations of the United Kingdom and Spanish subsidiaries, which together operate across Europe and South Africa.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Annual profits - Rate of surprise